The Motley Fool·6h ago·Reuben Gregg BrewerEli Lilly's Decade of Dominance: GLP-1 Boom Masks Rising Competition$LLY surged 1,100% in ten years via GLP-1 drugs, but 39x P/E ratio and patent risks loom. PFELLYNVOGLP-1 drugspharmaceutical competition
The Motley Fool··Reuben Gregg Brewer